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Purpose: In OA cartilage, the metabolic activity of chondrocytes
is altered dramatically by site, but the mechanism(s) for the
changes is not known well. The purpose of this study is to deter-
mine possible regulatory molecules for chondrocyte anabolism
in OA.
Methods: In order to determine the candidate molecules which
may regulate chondrocyte anabolism in OA, cartilages were ob-
tained from 10 end-stage OA knees at macroscopically preserved
areas and degenerated areas. RNA was extracted from the 10
pairs of cartialge samples, and the proﬁles of gene expression at
respective areas were determined by microarray analysis (U133
Plus 2.0, Affymetrix). Linear regression analysis was performed
to evaluate the relatiohship between the expression of type II
collagen or aggrecan and that of the growth factors which were
known to have anabolic effects on chondrocytes (TGF-βs, BMPs,
IGFs, CTGF). The correlation was also investigated between
the cartilage matrices and receptors and endogenous inhibitors
for the growth factors. Further, the correlation was investigated
between the cartilage matrices and the cartilage related SOXs
(SOX5, SOX6, SOX9).
For some candidate molecules, the correlation of expression was
conﬁrmed by an analysis using real-time PCR and laser capture
microdissection (LCM). For this, OA cartilages were acquired
from another 10 OA knees at various sites in preserved and
degenerated areas. Cryosections were prepared and divided into
three cartilage zones (superﬁcial, middle, and deep zones) by
LCM (PixCell IIe, Arcturus). The expression of cartilage matrices
and candidate molecules was evaluated in respective zones by
real-time PCR.
Results: In the microarray analysis, a signiﬁcant correlation
was observed between the expression of type II collagen and
aggrecan, which was conﬁrmed by the real-time PCR analysis
coupled with LCM. The result of microarray analysis revealed
that the expression of type II collagen was positively correlated
with that of IGF-2 and TGF-β receptors (Table 1). Of these, the
signiﬁcance of correlation between type II collagen and IGF-2
was conﬁrmed by the real-time PCR analysis. Meanwhile, the
expression of aggrecan was positively correlated with that of IGF-
Table 1. Correlation of expression between cartilage matrices and growth fac-
tors, growth factor related molecules
Cartilage Growth factors and related molecules
matrices Positively correlated Negatively correlated
Type II collagen IGF-2* (r = 0.59, P < 0.01)
TGF-β RI (r = 0.45, P < 0.05)
TGF-β RII (r = 0.47, P < 0.05)
Aggrecan IGF-2* (r = 0.78, P< 0.01) IGFBP-1 (r = -0.60, P < 0.01)
IGF-2 R (r = 0.78, P < 0.01) IGFBP-3* (r = -0.65, P < 0.01)
IGFBP-4 (r = -0.64, P < 0.01)
IGFBP-5 (r = -0.68, P < 0.01)
IGFBP-6 (r = -0.64, P < 0.01)
IGFBP-7* (r = -0.62, P < 0.01)
TGF-β1* (r = 0.70, P < 0.01) LTBP-I (r = -0.47, P < 0.05)
TGF-β RII (r = 0.66, P < 0.01) LTBP-2 (r = -0.46, P < 0.05)
TGF-β RIII (r = 0.79, P < 0.01) LTBP-3 (r = -0.46, P < 0.05)
*signiﬁcance of correlarion was conﬁrmed by real-time PCR analysis. IGFBP,
IGF binding protein; LTBP, latent TGF-β binding protein.
2, IGF-2 receptor, TGF-β1, and TGF-β receptors, and negatively
correlated with that of IGF binding proteins and latent TGF-β
binding proteins (Table 1). The real-time PCR analysis conﬁrmed
signiﬁcant correlations between aggrecan and IGF-2, TGF-β1,
and IGF binding proteins-3 and -7.
The expression of type II collagen and aggrecan was both
signiﬁcantly correlated with that of SOX9, but not with SOX5 or
SOX6, which was also conﬁrmed by the real-time PCR analysis.
Conclusions: Although the anabolic activity of chondrocytes is
highly enhanced in the preserved areas in OA cartilage, it is
considerably reduced at the degenerated areas, which may be
responsible for the loss of cartilage matrix in OA. The result
of this study suggested that the change in IGF-2 and TGF-β1
activities may account for such regional difference in chondrocyte
anabolism. SOX9 could be another factor for the regional change,
though the relationship between SOX9 and the above two growth
factors is still left to be determined. Although further experiments
are necessary, this result could be a novel clue to dissect the
mechanisms for altered chondrocyte metabolism in OA.
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Purpose: Sporadic chondrocalcinosis is a common human dis-
order characterized by the deposition of calcium-containing crys-
tals, mostly calcium pyrophosphate dihydrate (CPPD), within
articular cartilage. ANK is a multipass transmembrane protein
transporter, thought to play a role in the export of intracellu-
lar inorganic pyrophosphate (iPPi), and so to be implicated in
chondrocalcinosis. Two others proteins play a major role in the
metabolism of inorganic pyrophosphate: PC-1, that generates
extracellular inorganic pyrophosphate (ePPi) from nucleotides
triphosphates, and TNAP (Tissue Non speciﬁc Alkaline Phos-
phatase), that cleaves one molecule of ePPi into two molecules
of extracellular inorganic phosphate (ePi). Transforming growth
factor-β1 (TGF-β1) was shown to enhance ePPi production by
articular chondrocytes, markedly in old patients than in young
patients, this was closely related to the occurrence of sporadic
chondrocalcinosis. Therefore, we investigated the contribution of
ANK to the production of extracellular ePPi by chondrocytes and
the signaling pathways involved in the regulation of Ank gene by
TGF-β1.
Methods: Chondrocytes were exposed to 10 ng/ml of TGF-β1,
and Ank expression was measured by quantitative PCR and
Western blot analyses. ePPi and ePi were quantiﬁed concomi-
tantly by a ﬂuorescence assay in cell supernatants. SiRNA tech-
nology was used to deﬁne the respective role of Ank and PC-1
in TGF-β1-induced ePPi generation. Finally, selective inhibitors
and dominant negative/constitutively active overexpression plas-
mids strategy were used to explore the contribution of Ras,
Raf-1, MAPKs (ERK 1/2 and p38 MAPK), Smad, PKA and PKC
pathways to Ank induction by TGF-β1.
Results: TGF-β1 strongly increased Ank expression, maximally
by 4.5 fold at the mRNA and by 4-fold at the protein level. PC-1
mRNA and protein levels were induced with the same intensity,
but in a more delayed fashion, whereas TNAP was repressed
by 2-fold under TGF-β1 stimulation. Moreover, ePPi production
was induced 5-fold after 24 h TGF-β1 exposure, whereas ePi
levels were not affected under the same conditions. Then, we
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demonstrated that siRNA for Ank reduced 4-fold more than
siRNA for PC-1 the inducing effect of TGF-β1 on ePPi levels.
We showed that neither SB203580 (a p38 MAPK inhibitor), nor
RcAMP (a PKA inhibitor) were able to modulate Ank induc-
tion, but that PD98059 (a MEK 1 inhibitor) was strongly active,
ensuring a 50% inhibition of TGF-β-1-induced Ank expression.
On the other hand, the effect of PKC inhibitors depended on
their selectivity: PKCδ inhibitor (rottlerin) was weakly effective
compared to Ca2+-dependent PKC inhibitor (Gö6976), that di-
minished Ank expression by 60%, suggesting the involvement
of calcium-dependent PKC in the regulation of Ank gene by
TGF-β1. Finally, we demonstrated with plasmids transfection the
involvement of Ras, Raf-1 and conﬁrmed the contribution of ERK
in Ank mRNA regulation. However, overexpression of Smad 7
did not affect Ank expression, showing that Smad-dependent
signaling events downstream to TGF-β1 were not implicated.
Conclusions: These results indicate that TGF-β1 mediates an
increase in ePPi concentration, mainly by induction of Ank ex-
pression, which depends on activation of Ras, Raf-1, ERK and
Ca2+-dependent PKC pathways in chondrocyte. Our results un-
derline the interest to modulate Ras/Raf-1/ERK or PKC signaling
pathways in chondrocytes, as it could open insights for the treat-
ment of sporadic chondrocalcinosis.
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Purpose: It has been reported that the early stage of osteoarthri-
tis (OA) is characterized by hypertrophic differentiation and apop-
tosis of chondrocytes, which mimics the developmental process
of growth plate chondrocytes. The level of inorganic phosphate
(Pi) elevates at the site of cartilage mineralization, and previous
studies have proposed that Pi entry into hypertrophic chondro-
cytes may act as an apoptogen. The Bcl-2 family proteins, which
consist of pro- and anti-apoptotic members, are major regulators
of mitochondria-initiated apoptosis. In this study, we investigated
how they determine the cell fate of chondrocytes.
Methods: We developed an in vitro system to analyze the mech-
anism of hypertrophic differentiation and apoptosis of chondro-
cytes using chondrogenic ATDC5 cells. Using this culture system,
the expression levels of pro- and anti-apoptotic Bcl-2 members
were analyzed by real time RT-PCR or western blotting, and
their roles in chondrocyte apoptosis by gene overexpression
and gene silencing. Association between anti-apoptotic member
Bcl-xL and pro-apoptotic member Bnip3 was examined by im-
munoprecipitation, and their expression patterns in growth plate
chondrocytes were investigated by immunohistological staining.
Finally, we generated chondrocyte-speciﬁc knockout mice of anti-
apoptotic Bcl-2 family member protein Bcl-xL using the Cre-loxP
recombination system, and examined its roles in vivo.
Results: When differentiated ATDC5 cells were treated with Pi,
they mineralized the surrounding matrix and underwent rapid
apoptosis as evidenced by nuclear condensation, Caspase-3
& 7 activation, and Lamin proteolysis. In this culture system,
among 15 pro-apoptotic Bcl-2 family members, 7 molecules in-
creased their expression levels during the course of hypertrophic
differentiation, and two in response to Pi stimulation. Of these,
gene silencing of a proapoptotic BH3-only molecule bnip3 by
RNA interference signiﬁcantly suppressed Pi-induced apoptosis.
Conversely, among anti-apoptotic members examined, overex-
pression of bcl-xL suppressed, and its knockdown promoted
apoptosis. The susceptibility to apoptosis by bcl-xL knockdown
was partially restored by simultaneous silencing of bnip3. Pi
treatment markedly upregulated the protein levels of Bnip3 with-
out affecting Bcl-xL levels. Bnip3 was associated with Bcl-xL and
attenuated its anti-apoptotic effect in chondrocytes. Immunohisto-
logical examination of murine growth plates revealed that Bcl-xL
expressed uniformly in the growth plate chondrocytes, whereas
Bnip3 expression was exclusively localized in the hypertrophic
chondrocytes. Finally, we generated chondrocyte-speciﬁc bcl-xL
knockout mice using the Cre-loxP recombination system, and
provided evidence that the hypertrophic chondrocyte layer was
markedly shortened in those mice owing to massive chondro-
cyte apoptosis and that the mice exhibited dwarﬁsm as a result.
Furthermore, Bnip3 expression was decreased in hypertrophic
chondrocytes in mice fed with a low phosphate diet, and the
abnormalities in the growth plate were almost completely res-
cued.
Conclusions: Increase in Pi levels in hypertrophic zone causes
upregulation of Bnip3 in chondrocytes, which binds to Bcl-xL
and consequently impairs its anti-apoptotic effect, and ﬁnally
causes apoptosis of the cells. Our observations will open a
new therapeutic approach for OA by modulating the function
of Bcl-xL/Bnip3 axis and consequently regulating chondrocyte
apoptosis.
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INTERLEUKIN 6 (IL-6) SIGNALING MODULATES
ANABOLIC AND CATABOLIC PATHWAYS IN HUMAN
ARTICULAR CHONDROCTYES
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Purpose: Interleukin 6 (IL-6) production is elevated in affected
joints of osteoarthritis (OA) patients. The central role played by
IL-6 in joint inﬂammation and destruction has suggested thera-
pies targeting IL-6 for treatments of arthritic diseases. However,
increased severity of spontaneous cartilage damage in IL6-/-
mice suggests a protective role by IL-6 in joint homeostasis. The
aim of this study was to examine the effects of blocking IL-6 sig-
naling on both catabolic and anabolic gene regulation in human
primary chondrocytes (HACs) by small interfering RNA (siRNA)
technology and antibody treatment.
Methods: Small interfering RNA-mediated gene-speciﬁc knock-
down of IL-6 signaling components (IL-6 or IL-6R) was applied
to achieve blockade of IL-6 signaling in human primary chondro-
cytes (HACs) treated with catabolic (IL-1β) or anabolic (TGF-β
or IGF-1+OP-1) stimuli. To conﬁrm the siRNA effects in chon-
drocytes, a neutralizing anti-IL-6 antibody was also studied for
effects in response to IL-1β treatment. Expression of the mRNA
for chondrocytic genes was determined by quantitative real-time
PCR (Taqman). The protein level of IL-6 and MMP-13 were
measured using immunochemical based assays.
Results: Transfection of IL-6 and IL-6R siRNA into chondrocytes
resulted in signiﬁcant gene speciﬁc knockdown of IL-6 and IL-
6R mRNA, respectively. In addition, knockdown of IL-6 led to
a drastic reduction in IL-1β-induced expression of IL-6 mRNA
and protein. Decreased IL-6 expression also led to a marked re-
duction in IL-1β-induced expression of pro-inﬂammatory cytokine
TNF-α, and cartilage degrading enzymes such as MMP-13 and
ADAMTS-4. The inhibitory effects by IL-6 siRNA were speciﬁc to
IL-6 signaling, as similar effects were exhibited by both IL-6 neu-
tralizing antibody and IL-6R siRNA. Surprisingly, IL-6 appears to
modulate gene expression in chondroctyes under anabolic stim-
ulation. We found that the expression of several essential ECM
and cartilage components, in particular collagen II (Col2a), was
not induced by TGF-β or IGF-1/OP-1 in cells transfected with
IL-6 siRNA.
